Mir-338-3p Inhibits Malignant Biological Behaviors of Glioma Cells by Targeting MACC1 Gene
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
MiR-338-3p has previously been implicated in tumor suppression in hepatocarcinoma, gastric cancer, and brain cancer.
“MiR-338-3p has previously been implicated in tumor suppression in hepatocarcinoma, gastric cancer, and brain cancer [40–44].”
From MiR-338-3p regulates neuronal maturation and suppresses glioblastoma proliferation. (2017) · cites this paper as [40]
Overexpression of miR-338-3p reduces cell viability and increases apoptosis in certain glioma cell lines.
“Another study shows reduced cell viability and increased apoptosis in certain glioma cell lines following overexpression of miR-338-3p”
From MiR-338-3p regulates neuronal maturation and suppresses glioblastoma proliferation. (2017) · cites this paper as [40]
Reduced cell viability and increased apoptosis may at least partially explain the change in proliferation observed in this study.
“which may at least partially explain the change in proliferation we observe [40].”
From MiR-338-3p regulates neuronal maturation and suppresses glioblastoma proliferation. (2017) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
No references could be resolved yet.
Research works printed but not linked: 21
- [1]Khan UA Bhavsar A Asif H Treatment by specialist surgical neurooncologists improves survival times for patients with malignant glioma J Neurosurg 2015 122 2 297 302 25415070
- [2]Hong Y Shang C Xue YX Liu YH Silencing of Bmi-1 gene enhances chemotherapy sensitivity in human glioblastoma cells Med Sci Monit 2015 21 1002 7 25858624 PMC4399481
- [3]Chien LN Ostrom QT Gittleman H International differences in treatment and clinical outcomes for high grade glioma PLoS One 2015 10 6 e0129602 26061037 PMC4465035
- [4]Shang C Hong Y Guo Y MiR-210 up-regulation inhibits proliferation and induces apoptosis in glioma cells by targeting SIN3A Med Sci Monit 2014 20 2571 77 25481483 PMC4266365
- [5]Zhang H Guo Y Shang C miR-338-3p downregulated TCF21 to inhibit KISS1 in renal cancer Urology 2012 80 6 1298 302 23206776
- [6]Shen S Guo X Yan H A miR-338-3p-YAP positive feedback loop promotes organ size and tumorigenesis Cell Res 2015 25 9 997 1012 26272168 PMC4559818
- [7]Chen H Li X Li W Zheng H miR-21 can predict response to temozolomide in patients with glioblastoma multiforme, independently of O6-methylguanine-DNA methyltransferase Transl Med 2015 13 69 PMC4345002 25890369
- [8]Shang C Hong Y Guo Y Influence of the MACC1 gene on sensitivity to chemotherapy in human U251 glioblastoma cells Asian Pac J Cancer Prev 2015 16 1 195 99 25640351
- [9]Shang C Guo Y Hong Y MiR-21 up-regulation mediates glioblastoma cancer stem cells apoptosis and proliferation by targeting FASLG Mol Biol Rep 2015 42 3 721 27 25394756
- [10]Tanaka S Louis DN Curry WT Diagnostic and therapeutic avenues for glioblastoma: No longer a dead end? Nat Rev Clin Oncol 2013 10 1 14 26 23183634
- [11]Furnari FB Fenton T Bachoo RM Malignant astrocytic glioma: Genetics, biology, and paths to treatment Genes Dev 2007 21 21 2683 710 17974913
- [12]Su X Chen HL Wang ZY Lan Q Relationship between tumour location and preoperative seizure incidence in patients with gliomas: A systematic review and meta-analysis Epileptic Disord 2015 17 4 397 408 26643505
- [13]Chen T Wang XY Li C Xu SJ Downregulation of microRNA-124 predicts poor prognosis in glioma patients Neurol Sci 2015 36 1 131 35 25112530
- [14]Wang L Shi ZM Jiang CF MiR-338-3p acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-inducedapoptosis in glioma Oncotarget 2014 5 14 5416 27 24980823 PMC4170647
- [15]Lu YM Shang C Ou YL miR-200c modulates ovarian cancer cell metastasis potential by targeting zinc finger E-box-binding homeobox 2 (ZEB2) expression Med Oncol 2014 31 8 134 25052237
- [16]Stein U Walther W Arlt F MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis Nat Med 2009 15 1 59 67 19098908
- [17]Ge Y Meng X Zhou Y Positive MACC1 expression correlates with invasive behaviors and postoperative liver metastasis in colon cancer Int J Clin Exp Med 2015 8 1 1094 100 25785098 PMC4358553
- [18]Huang N Wu Z Lin L MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling Oncotarget 2015 6 17 15222 34 25945841 PMC4558147
- [19]Hagemann C Fuchs S Monoranu CM Impact of MACC1 on human malignant glioma progression and patients’ unfavorable prognosis Neuro Oncol 2013 15 12 1696 709 24220141 PMC3829600
- [20]Wang Y Hong Q Wang J Downregulated expression of metastasis associated in colon cancer 1 (MACC1) reduces gallbladder cancer cell proliferation and invasion Tumour Biol 2014 35 4 3771 78 24425103
- [21]Zhang Y Wang Z Chen M MicroRNA-143 targets MACC1 to inhibit cell invasion and migration in colorectal cancer Mol Cancer 2012 11 23 22533346 PMC3351020
Cited by
Sorted by citations
MiR-338-3p regulates neuronal maturation and suppresses glioblastoma proliferation.
Howe, J. R., Li, E. S., Streeter, S. E., Rahme, G. J., Chipumuro, E., Russo, G. B., Litzky, J. F., Hills, L. B., Rodgers, K. R., Skelton, P. D., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177661 · Cited by 41 · see citing works
- Authors
- Shang, C., Hong, Y., Guo, Y., & Xue, Y.
- Affiliations
- Department of Neurobiology, College of Basic Medicine, China Medical University, Shenyang, Liaoning, China (mainland)
- Department of Neurosurgery, Shengjing Hospital, China Medical University, Shenyang, Liaoning, China (mainland)
- Department of Central Laboratory, School of Stomatology, China Medical University, Shenyang, Liaoning, China (mainland)
- Venue
- Medical Science Monitor
- Published
- 2016-03-03
- Volume
- 22
- Pages
- 710-716
- ISSN
- 1643-3750
- PMC
- PMC4780270
- Cited by
- 22
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
